Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Brussels South Charleroi BioPark Dev from Charleroi, company number BE0479250670, closed financial year 2025 with a result of € -248,813 after tax. For that financial year Brussels South Charleroi BioPark Dev recorded a gross margin of € 80,186 and equity of € 327,454. Compared with financial year 2024, the result moved from € -437,752 to € -248,813. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ 327,454
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -248,813
▲ 43 % less loss than in 2024
Profit after tax over the fiscal year.
€ 105,026
▲ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -847,546.
People and assets in 2025
3.8
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 277,210
▲ 25% vs 2024
€ 72,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 36,388
▼ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 191,958
▲ 120% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,562
▲ 90% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 79,796 | € -83,035 | € -179,754 | € 80,186 | ▲ € 259,940 |
| Profit after taxes | € 6,128 | € -162,841 | € -437,752 | € -248,813 | ▲ € 188,939 |
| Equity | € 676,861 | € 514,020 | € 326,267 | € 327,454 | |
| Total debts | € 88,010 | € 190,480 | € 172,795 | € 341,333 | ▲ 98% |
| Cash | € 210,525 | € 363,431 | € 71,595 | € 105,026 | ▲ 47% |
| Retained profit | € 1,861 | € -160,980 | € -598,733 | € -847,546 | ▼ € 248,813 |
| Balance sheet total | € 764,871 | € 704,499 | € 499,063 | € 668,787 | ▲ 34% |
| Employees (FTE) | - | 1.8 | 3.5 | 3.8 | ▲ 0.3 |
Key figures of Brussels South Charleroi BioPark Dev, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Brussels South Charleroi BioPark Dev?
What happened at Brussels South Charleroi BioPark Dev in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- 6K VENTURE CAPITAL stepped down as director. NBB
- Michel COULON stepped down as director. NBB
- IGRETEC SCRL stepped down as director. NBB
- UNIVERSITE DE MONS stepped down as director. NBB
- SAMBRINVEST SPIN-OFF/SPIN-OUT SA stepped down as director. NBB
- IMPACTHEO SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 248,813. Source: NBB ↗
- IGRETEC SCRL became a director. NBB
In short
From € 6,128 profit in 2022 to € 248,813 loss in 2025.
Paid € 4,347 in corporate taxes since 2022.
Best year ever: 2022, with € 6,128 profit.
On average € 21,100 of value added per employee in 2025.
A new publication or filing at Brussels South Charleroi BioPark Dev? We notify you, reason included.
Follow Brussels South Charleroi BioPark DevDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of IMPACTHEO, SAMBRINVEST SPIN-OFF/SPIN-OUT, Charleroi Entreprendre comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Brussels South Charleroi BioPark DevThe shares are held by IMPACTHEO (32.8%), SAMBRINVEST SPIN-OFF/SPIN-OUT (32.8%) and Charleroi Entreprendre (31.3%).
Directors
According to the 2025 annual accounts
Director · represented by Héléna POZIOS
Also active at: Charleroi Entreprendre, HOME EOS, FONDS D'INVESTISSEMENT POUR LA DIVERSIFICATION INDUSTRIELLE DE LA REGION DE CHARLEROI, Biometh Quality Product, FLIPAW, TAFSQUARE, XIMEO, STEEL ESTATE +7 more
since 2023 · until 2031
Michel COULON
Director
Also active at: Palais des Beaux Arts de Charleroi, BIOPOLE ULB - CHARLEROI en abrégé BUC, Centre universitaire Zénobe Gramme
since 2019 · until 2031
Director · represented by Nathalie CZERNIATYNSKI
Also active at: CENEO, Société Nationale de Construction Aérospatiale, CENTRE D'EXCELLENCE EN TECHNOLOGIES DE L'INFORMATION ET DE LA COMMUNICATION, CITÉ DES MÉTIERS DE CHARLEROI, WALLONIE DEVELOPPEMENT
since 2025 · until 2031
Brigitte GOSSIAUX
Director
since 2019 · until 2025
Nathalie CZERNIATYNSKI
Director
Also active at: Charleroi Entreprendre, Starter Fund, SOCIETE WALLONNE DES AEROPORTS, Société de Gestion de l'Aérodrome de Spa
since 2019 · until 2025
Director · represented by Céline THILLOU
Also active at: MAISON DE L'ENTREPRISE, Centre Européen d'Entreprise et d'Innovation (CEEI), TECHNOCITE, Forum for cleantech, CEDREBEL, BIOWIN, FONDATION SUSA
since 2025 · until 2031
Chairman of the board · represented by Grégoire DUPUIS
Also active at: Chauraci, CHARPENTES JONCKHEERE SPANTEN, FERNAND GEORGES, Charleroi Entreprendre, PRODUCTION INDUSTRIELLE DE COMPOSANTS, BRUSSELS SOUTH CHARLEROI AIRPORT, Starter Fund, VENGO +13 more
since 2022 · until 2025
Cédric SZPIRER
Director
Also active at: EEBIC, 50°NORTH VENTURES, USQUARE INCUBATOR, SECOYA Technologies
since 2022 · until 2025
Céline THILLOU
Director
since 2015 · until 2025
Daniele CARATI
Director
since 2019 · until 2025
SAMBRINVEST SPIN-OFF/SPIN-OUT SA
Director · represented by Elisabeth DE HALLEUX
Also active at: BE ANGELS, 50°NORTH VENTURES, THEODORUS III, EMAsphere, AQUILON PHARMACEUTICALS, APIQUIET, BigCaptain, WE INVEST REAL ESTATE +25 more
since 2025 · until 2031
Director · represented by Danièle Carati
Also active at: Centre d'accompagnement de projets innovants, 50°NORTH VENTURES, THEODORUS III, Pré Seed Fund, THEODORUS IV, E-HEALTH VENTURE, Advanced Engineering Accelerator, Boost Engineering Pre-Seed Fund
since 2025 · until 2031
Denis LESOIL
Director
since 2020 · until 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
QbD Wallonia
€ 1.5 million gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.250.670
- VAT number
- BE 0479.250.670
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- Brussels South Charleroi BioPark Dev · BSCB Dev.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 January 2003
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige zakelijke dienstverlening, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied